Vancomycin AUC/MIC ratio and 30-day mortality in patients with Staphylococcus aureus bacteremia

by Holmes, N., Turnidge, J., Munckhof, W., Robinson, James, Korman, T., O'Sullivan, M., Anderson, T., Roberts, S., Warren, S., Gao, W., Howden, B., Johnson, P.
Published 2013

Vancomycin minimum inhibitory concentration, host comorbidities and mortality in staphylococcus aureus bacteraemia

by Holmes, N., Turnidge, J., Munckhof, W., Robinson, James, Korman, T., O'Sullivan, M., Anderson, T., Roberts, S., Warren, S., Gao, W., Johnson, P., Howden, B.
Published 2013

Antibiotic choice may not explain poorer outcomes in patients with staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations

by Holmes, N., Turnidge, J., Munckhof, W., Robinson, J., Korman, T., O'Sullivan, M., Anderson, T., Roberts, S., Gao, W., Christiansen, Keryn, Coombs, Geoffrey, Johnson, P., Howden, B.
Published 2011

Genetic and Molecular Predictors of High Vancomycin MIC in Staphylococcus aureus Bacteremia Isolates

by Holmes, N., Turnidge, J., Munckhof, W., Robinson, James, Korman, T., O'Sullivan, M., Anderson, T., Roberts, S., Warren, S., Coombs, Geoffrey, Tan, H., Gao, W., Johnson, P., Howden, B.
Published 2014